RNAi to treat SARS-CoV-2-variant proofing the next generation of therapies차세대 치료법을 입증하는 SARS-CoV-2 변이체를 치료하는 RNAiArticle Published on 2022-04-072022-09-11 Journal: EMBO Molecular Medicine [Category] COVID19(2023년), MERS, SARS, 변종, 진단, 치료제, [키워드] animals Antiviral Antiviral effect approach approved effective Efficacy eliminating market Medicine molnupiravir Older pathology Paxlovid reducing RNA RNAi SARS-CoV-2 siRNAs therapy treat Treatment variant Viral viral replication [DOI] 10.15252/emmm.202215811 PMC 바로가기 [Article Type] Article
Antiviral Efficacy of Molnupiravir for COVID-19 Treatment코로나19 치료를 위한 몰누피라비르의 항바이러스 효능Article Published on 2022-04-062022-09-11 Journal: Viruses [Category] COVID19(2023년), SARS, 변종, 치료제, [키워드] 95% CI active against Administered Antiviral antiviral drug antiviral drugs antiviral efficacy antiviral efficacy. coronavirus COVID-19 COVID-19 pandemic exacerbated expected global pandemic Government granular growth infected cell infected cells infectiousness inhibit Intervention mathematical molnupiravir per day pharmaceutical Pharmaceutical interventions public health reduce Replication risk SARS-CoV-2 SARS-CoV-2 variants Seven treated Viral load virus [DOI] 10.3390/v14040763 PMC 바로가기 [Article Type] Article
Two Green Micellar HPLC and Mathematically Assisted UV Spectroscopic Methods for the Simultaneous Determination of Molnupiravir and Favipiravir as a Novel Combined COVID-19 Antiviral Regimen새로운 결합된 COVID-19 항바이러스 요법으로서 Molnupiravir와 Favipiravir의 동시 측정을 위한 2개의 Green Micellar HPLC 및 수학 보조 UV 분광법Article Published on 2022-04-042022-09-11 Journal: Molecules [Category] COVID19(2023년), SARS, 치료기술, 치료제, [키워드] adjusted Analytical chemistry Antiviral applied Brij-35 classical Combination Combined composed conditions construction COVID-19 COVID-19 pandemic COVID-19 regimen Determination drug Efficacy extraction Favipiravir FIVE flow rate Genetic Genetic algorithm green harmony HPLC increase initiated isocratic less Liquid chromatography lung Lungs medication micellar liquid chromatography molnupiravir monobasic potassium phosphate novel overlapping partial least square partial least squares PCR phosphate plateau Potassium potassium phosphate predicted prevented Principal component regimen released SARS-CoV-2 virus SDS similarity Simultaneous Spread Tablet the SARS-CoV-2 virus trials UV–VIS Spectrophotometry Viral transmission [DOI] 10.3390/molecules27072330 PMC 바로가기 [Article Type] Article
Molnupiravir and Its Antiviral Activity Against COVID-19Review Published on 2022-04-042023-07-01 Journal: Frontiers in Immunology [Category] COVID19(2023년), SARS, [키워드] Antiviral COVID-19 molnupiravir orally bioavailable Safety SARS-CoV-2 [DOI] 10.3389/fimmu.2022.855496 PMC 바로가기 [Article Type] Review
Molnupiravir: A lethal mutagenic drug against rapidly mutating severe acute respiratory syndrome coronavirus 2—A narrative reviewReview Published on 2022-04-022022-10-04 Journal: Journal of medical virology [Category] COVID19(2023년), SARS, 변종, 치료제, [키워드] β‐d‐N4‐hydroxycytidine acute respiratory syndrome administration antiviral agent cause clinical clinical trials coronavirus coronavirus disease COVID‐19 COVID‐19 DNA Efficacy EIDD‐2801 error catastrophe expected host cell in vivo experiment inhibit molnupiravir Mutagenesis mutagenic mutated pandemic Patient Placebo RdRP recent finding Replication reported RNA‐dependent RNA polymerase SARS‐CoV‐2 therapeutic efficacy therapeutic strategy therapy Trial turn variant Viral RNA virus [DOI] 10.1002/jmv.27730 PMC 바로가기 [Article Type] Review
Pharmacological treatment of COVID-19: an opinion paperCOVID-19의 약리학적 치료: 의견서Review Published on 2022-04-012022-09-11 Journal: Revista española de quimioterapia : publicación [Category] COVID19(2023년), SARS, 치료제, [키워드] adalimumab Anakinra approach AZD7442 Azithromycin Banlanivimab Baricitinib BRII-196 BRII-198 canakinumab Casirivimab Certolizumab Ciganilmab Colchicine college Committee convalescent convalescent plasma COVID-19 Critical Dexamethasone drug drugs effective Efficacy English Etanercept etesevimab Evusheld Favipiravir fluvoxamine Golimumab help Hydroxychloroquine Imdevinab immune response Immunotherapy indication infliximab itolizumab Ivermectin Lemilumab Lopinavir Lopinavir/ritonavir Medicines metformin molnupiravir offer Pandemia pandemic Paxlovid PF-07321332 physician precocity prevented Ravulizumab Remdesivir Ritonavir ruxolitinib sarilumab SARS-CoV-2 Scientific Committee Sotrovimab Spanish the vaccine therapeutic Tixagevimab Tocilizumab Tofacitinib Treatment Vaccine virus Vitamin Vitamin D [DOI] 10.37201/req/158.2021 PMC 바로가기 [Article Type] Review
Therapeutic treatment with an oral prodrug of the remdesivir parental nucleoside is protective against SARS-CoV-2 pathogenesis in miceResearch Article Published on 2022-03-222022-10-04 Journal: Science Translational Medicine [Category] COVID19(2023년), MERS, SARS, 변종, 치료제, [키워드] acute respiratory syndrome administration Antiviral antiviral activity antivirals approval Breakthrough infection conserved coronavirus coronavirus disease CoV COVID-19 Culture description develop dose-dependent drug effective EUA exhibited GS-441524 in vitro in vivo increasingly infected with SARS-CoV-2 Infection lung lung cell lung cell line MERS-CoV mice Middle East molnupiravir monoclonal antibodies neutralization outpatients pandemic parent nucleoside parental pharmacokinetic Protective Pulmonary function reduced Remdesivir respiratory RNA-dependent RNA polymerase Safe SARS-CoV-2 SARS-CoV-2 pathogenesis SARS-CoV-2 variant Support target therapeutic therapeutic efficacy translated Treatment vaccination Vaccines Viral load Viral protein virus waning immunity [DOI] 10.1126/scitranslmed.abm3410 PMC 바로가기 [Article Type] Research Article
The Anti-COVID-19 Drug Remdesivir Promotes Oncogenic Herpesvirus Reactivation through Regulation of Intracellular Signaling Pathways항-COVID-19 약물 렘데시비르, 세포내 신호 전달 경로의 조절을 통해 발암성 헤르페스바이러스 재활성화 촉진Article Published on 2022-03-152022-09-12 Journal: Antimicrobial Agents and Chemotherapy [Category] SARS, 진단, [키워드] approved caused COVID-19 COVID-19 patients drug EBV herpesvirus herpesviruses infected cells Intracellular intracellular signaling KSHV molnupiravir oncogenic Pathways Reactivation Remdesivir SARS-CoV-2 SARS-COV-2 infection treating COVID-19 virion production virus [DOI] 10.1128/aac.02395-21 PMC 바로가기 [Article Type] Article
A Systematic Review of the Global Intervention for SARS-CoV-2 Combating: From Drugs Repurposing to Molnupiravir ApprovalReview Published on 2022-03-152023-07-01 Journal: Drug design, development and therapy [Category] SARS, [키워드] clinical trials Drug repurposing molnupiravir Paxlovid SARS-CoV-2 [DOI] 10.2147/DDDT.S354841 PMC 바로가기 [Article Type] Review
Antiviral activity of molnupiravir against COVID-19: a schematic review of evidencesReview Published on 2022-03-102022-10-28 Journal: Bulletin of the National Research Centre [Category] COVID-19, [키워드] active form animal model animal models antiviral activity Antiviral effect antiviral efficacy antiviral medicine Cell clinical clinical trials conducted country COVID-19 death Efficacy and safety EIDD-1931 EIDD-2801 evaluate Evidence highly pathogenic Hospitalization in vitro in vivo individuals with COVID-19 infected with COVID-19 lab mechanism of action medication moderate molnupiravir multiple coronaviruses outcome pathogen reduced Replication Research responsible risk SARS-CoV-2 Severe case Spread Treatment Viral RNA [DOI] 10.1186/s42269-022-00753-9 PMC 바로가기 [Article Type] Review